“Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients With Type 2 Diabetes: Single-Blind Interventional Study With Placebo Control at Tertiary Care Setting Quetta”. Life and Science, vol. 6, no. 4, Oct. 2025, p. 06, https://doi.org/10.37185/LnS.1.1.870.